We are live on ! Find out more
IBIO icon

iBio
IBIO

16 hedge funds and large institutions have $2.1M invested in iBio in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

2% more capital invested

Capital invested by funds: $2.06M → $2.1M (+$36.8K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

16% less funds holding

Funds holding: 19 → 16 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$75.1K
2
UBS Group
UBS Group
Switzerland
+$19.6K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$9.8K
4
Creative Planning
Creative Planning
Kansas
+$3.27K

Top Sellers

Rank Fund Capital Flow
1
ACP
Arcus Capital Partners
Georgia
-$569K
2
Goldman Sachs
Goldman Sachs
New York
-$50K
3
Millennium Management
Millennium Management
New York
-$29.4K
4
Citadel Advisors
Citadel Advisors
Florida
-$29K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.3M +$9.8K +3 +0.8%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$246K – – –
BIT
3
BlackRock Institutional Trust
California
$129K – – –
S
4
SignatureFD
Georgia
$110K – – –
HighTower Advisors
5
HighTower Advisors
Illinois
$81K +$75.1K +23 New
Bank of New York Mellon
6
Bank of New York Mellon
New York
$62K – – –
Northern Trust
7
Northern Trust
Illinois
$47K – – –
RJA
8
Raymond James & Associates
Florida
$36K – – –
UBS Group
9
UBS Group
Switzerland
$25K +$19.6K +6 +600%
BA
10
BlackRock Advisors
Delaware
$15K – – –
BFA
11
BlackRock Fund Advisors
California
$11K – – –
Morgan Stanley
12
Morgan Stanley
New York
$9K – – –
State Street
13
State Street
Massachusetts
$8K – – –
Millennium Management
14
Millennium Management
New York
$7K -$29.4K -9 -82%
UAS
15
United Asset Strategies
New York
$7K – – –
Creative Planning
16
Creative Planning
Kansas
$2K +$3.27K +1 New
Fifth Third Bancorp
17
Fifth Third Bancorp
Ohio
$1K – – –
ACP
18
Arcus Capital Partners
Georgia
– -$569K -201 Closed
Goldman Sachs
19
Goldman Sachs
New York
– -$50K -18 Closed
Citadel Advisors
20
Citadel Advisors
Florida
– -$29K -10 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$9K -3 Closed
Bank of America
22
Bank of America
North Carolina
– -$6.53K -2 Closed

IBIO Hedge Fund Activity: Q2 2016 in Review

16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2016, worth a combined $2.1M — up 1.8% from $2.06M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IBIO and 2 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was HighTower Advisors, opening a new position worth an estimated $75.1K. The largest seller was Arcus Capital Partners, exiting entirely with an estimated $569K sold.

  • 16 institutional investors held iBio (IBIO) as of Q2 2016, down from 19 in Q1 2016.
  • Funds reported $2.1M of iBio stock for Q2 2016, up 1.8% quarter-over-quarter.
  • 2 funds opened new iBio positions in Q2 2016 and 5 closed out, a net change of -3 holders.
  • The largest iBio buyer in Q2 2016 was HighTower Advisors, an estimated $75.1K added.
  • The largest iBio seller in Q2 2016 was Arcus Capital Partners, an estimated $569K sold.

Based on aggregated 13F filings for Q2 2016.